Option Care Health (NASDAQ:OPCH) Earns Neutral Rating from JPMorgan Chase & Co.

Option Care Health (NASDAQ:OPCH)‘s stock had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Wednesday, Benzinga reports. They currently have a $33.00 price target on the stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 6.33% from the company’s current price.

Other research analysts have also issued research reports about the stock. Truist Financial set a $32.05 price target on shares of Option Care Health in a research note on Wednesday. Zacks Research raised shares of Option Care Health from a “strong sell” rating to a “hold” rating in a research report on Monday, July 6th. Stephens restated an “equal weight” rating and set a $24.00 price objective (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. UBS Group reaffirmed a “buy” rating on shares of Option Care Health in a research report on Tuesday, September 22nd. Finally, Barrington Research reaffirmed a “market perform” rating on shares of Option Care Health in a research note on Wednesday. Three equities research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. According to data from MarketBeat, Option Care Health has an average rating of “Hold” and an average price target of $29.70.

Option Care Health Trading Up 0.1%

Shares of Option Care Health stock traded up $0.04 during trading hours on Wednesday, hitting $31.04. The company’s stock had a trading volume of 11,424,895 shares, compared to its average volume of 2,817,709. Option Care Health has a 12 month low of $18.01 and a 12 month high of $36.80. The stock has a 50 day moving average of $23.78 and a 200 day moving average of $23.55. The company has a market capitalization of $4.65 billion, a PE ratio of 23.33, a price-to-earnings-growth ratio of 1.35 and a beta of 0.58. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The business had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.42 billion. During the same quarter in the previous year, the business posted $0.41 EPS. Option Care Health’s revenue for the quarter was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Analysts predict that Option Care Health will post 1.7 earnings per share for the current year.

Institutional Investors Weigh In On Option Care Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Central Pacific Bank Trust Division increased its position in shares of Option Care Health by 3.9% in the third quarter. Central Pacific Bank Trust Division now owns 14,369 shares of the company’s stock valued at $323,000 after acquiring an additional 540 shares during the last quarter. Engineers Gate Manager LP boosted its position in Option Care Health by 263.0% during the second quarter. Engineers Gate Manager LP now owns 43,560 shares of the company’s stock valued at $913,000 after purchasing an additional 31,561 shares during the last quarter. Squarepoint Ops LLC boosted its position in Option Care Health by 234.1% during the second quarter. Squarepoint Ops LLC now owns 434,408 shares of the company’s stock valued at $9,110,000 after purchasing an additional 304,376 shares during the last quarter. Empirical Finance LLC bought a new position in Option Care Health in the second quarter valued at approximately $595,000. Finally, Nykredit A S bought a new position in Option Care Health in the second quarter valued at approximately $56,000. 98.05% of the stock is owned by institutional investors.

Option Care Health News Roundup

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: CD&R and McKesson agreed to acquire Option Care Health for $32.05 per share in cash, representing a 37% premium to the unaffected price and an estimated enterprise value of approximately $5.8 billion. The transaction is the primary catalyst behind the stock’s surge and moves Option Care toward becoming a private company. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
• Positive Sentiment: The stock is trading near, but below, the $32.05 offer price. The remaining spread reflects investors’ assessment of deal-completion risk and potential timing, while the all-cash consideration provides a clearly defined valuation. Option Care Stock Trades Below McKesson’s Deal Price
• Neutral Sentiment: Citizens JMP and Barrington Research both reaffirmed “Market Perform” ratings. These actions do not materially change the investment outlook because the stock is now primarily driven by the pending acquisition rather than standalone earnings prospects. Option Care Health Stock Rating Reaffirmed as Market Perform
• Neutral Sentiment: Unusually heavy call-option activity and trading volume indicate strong investor interest following the buyout announcement, but these signals do not guarantee additional upside beyond the offer price.
• Negative Sentiment: Several shareholder-rights law firms are investigating whether the $32.05 price fairly values Option Care and whether company insiders received benefits unavailable to ordinary shareholders. Such reviews could create legal or timing uncertainty, although no challenge to the transaction has been reported. Ademi LLP Investigates Option Care Health Buyout

Option Care Health Company Profile

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.